Abstract B101: Engineered PD-1 variants as immunotherapies for cancer.

Abstract B101: Engineered PD-1 variants as immunotherapies for cancer. . 2016 Jan 1; b101-b101.

2016
https://researcherprofiles.org/profile/79290253